Rethinking the Preclinical Package for Chronic Kidney Disease: Why Pigs belong in the conversation
Drug development for chronic kidney disease has entered a more ambitious phase. SGLT2 inhibitors, non steroidal mineralocorticoid receptor...
Drug development for chronic kidney disease has entered a more ambitious phase. SGLT2 inhibitors, non steroidal mineralocorticoid receptor...
The challenge in translational research is not generating data but generating actionable confidence.
Pain and wound healing research demand models that accurately reflect human tissue structure, innervation, and functional recovery. While rodents...
Drug development rarely fails because a compound lacked activity. More often, it fails because preclinical models failed to predict clinical reality.